Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review

<p dir="ltr">Coronavirus disease 2019(COVID-19) is an ongoing global pandemic with a daily increasing number of affected individuals and a relatively high mortality rate. COVID-19 patients that develop cardiac injury are at increased risk of a worse clinical course with higher rates...

Full description

Saved in:
Bibliographic Details
Main Author: Arwa Saed Aldien (17302849) (author)
Other Authors: Gowrii S. Ganesan (17302852) (author), Farah Wahbeh (13192175) (author), Noor Al-Nassr (17302855) (author), Heba Altarawneh (17302858) (author), Lolwa Al Theyab (17302861) (author), Summia Saed Aldien (17302864) (author), Sara Tomerak (14683597) (author), Hiba Naveed (14683591) (author), Mohamed B. Elshazly (14779456) (author), Dalia Zakaria (14779459) (author)
Published: 2022
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513545114222592
author Arwa Saed Aldien (17302849)
author2 Gowrii S. Ganesan (17302852)
Farah Wahbeh (13192175)
Noor Al-Nassr (17302855)
Heba Altarawneh (17302858)
Lolwa Al Theyab (17302861)
Summia Saed Aldien (17302864)
Sara Tomerak (14683597)
Hiba Naveed (14683591)
Mohamed B. Elshazly (14779456)
Dalia Zakaria (14779459)
author2_role author
author
author
author
author
author
author
author
author
author
author_facet Arwa Saed Aldien (17302849)
Gowrii S. Ganesan (17302852)
Farah Wahbeh (13192175)
Noor Al-Nassr (17302855)
Heba Altarawneh (17302858)
Lolwa Al Theyab (17302861)
Summia Saed Aldien (17302864)
Sara Tomerak (14683597)
Hiba Naveed (14683591)
Mohamed B. Elshazly (14779456)
Dalia Zakaria (14779459)
author_role author
dc.creator.none.fl_str_mv Arwa Saed Aldien (17302849)
Gowrii S. Ganesan (17302852)
Farah Wahbeh (13192175)
Noor Al-Nassr (17302855)
Heba Altarawneh (17302858)
Lolwa Al Theyab (17302861)
Summia Saed Aldien (17302864)
Sara Tomerak (14683597)
Hiba Naveed (14683591)
Mohamed B. Elshazly (14779456)
Dalia Zakaria (14779459)
dc.date.none.fl_str_mv 2022-02-01T00:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.carrev.2021.04.007
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Systemic_Inflammation_May_Induce_Cardiac_Injury_in_COVID-19_Patients_Including_Children_and_Adolescents_Without_Underlying_Cardiovascular_Diseases_A_Systematic_Review/24459133
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Cardiovascular medicine and haematology
Coronavirus
COVID-19
Inflammation
Cardiac injury
Myocarditis
dc.title.none.fl_str_mv Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Coronavirus disease 2019(COVID-19) is an ongoing global pandemic with a daily increasing number of affected individuals and a relatively high mortality rate. COVID-19 patients that develop cardiac injury are at increased risk of a worse clinical course with higher rates of mortality. Increasing amounts of evidence suggest that a system-wide inflammatory response and a cytokine storm mediated type syndrome plays a crucial role in disease progression. This systematic review investigates the possible role of hyperinflammation in inducing cardiac injury as one of the severe complications of COVID-19. A systematic literature search was performed using PubMed, Embase and Scopus databases to identify relevant clinical studies that investigated cardiovascular injury manifestations and reported inflammatory and cardiac biomarkers in COVID-19 patients. Only 29 studies met our inclusion criteria and the majority of these studies demonstrated significantly elevated inflammatory and cardiac blood markers. It was evident that underlying cardiovascular diseases may increase the risk of developing cardiac injury. However, many COVID-19 patients included in this review, developed different types of cardiac injury without having any underlying cardiovascular diseases. Furthermore, many of these patients were either children or adolescents. Therefore, age and comorbidities may not always be the two main risk factors that dictate the severity and outcome of COVID-19. Further investigations are required to understand the underlying mechanisms of pathogenicity as an urgent requirement to develop the appropriate treatment and prevention strategies. These strategies may specifically target hyperinflammation as a suspected driving factor for some of the severe complications of COVID-19.</p><h2>Other Information</h2><p dir="ltr">Published in: Cardiovascular Revascularization Medicine<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.carrev.2021.04.007" target="_blank">https://dx.doi.org/10.1016/j.carrev.2021.04.007</a></p>
eu_rights_str_mv openAccess
id Manara2_0b04819075b300068afbbd62c306eebb
identifier_str_mv 10.1016/j.carrev.2021.04.007
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/24459133
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic ReviewArwa Saed Aldien (17302849)Gowrii S. Ganesan (17302852)Farah Wahbeh (13192175)Noor Al-Nassr (17302855)Heba Altarawneh (17302858)Lolwa Al Theyab (17302861)Summia Saed Aldien (17302864)Sara Tomerak (14683597)Hiba Naveed (14683591)Mohamed B. Elshazly (14779456)Dalia Zakaria (14779459)Biomedical and clinical sciencesCardiovascular medicine and haematologyCoronavirusCOVID-19InflammationCardiac injuryMyocarditis<p dir="ltr">Coronavirus disease 2019(COVID-19) is an ongoing global pandemic with a daily increasing number of affected individuals and a relatively high mortality rate. COVID-19 patients that develop cardiac injury are at increased risk of a worse clinical course with higher rates of mortality. Increasing amounts of evidence suggest that a system-wide inflammatory response and a cytokine storm mediated type syndrome plays a crucial role in disease progression. This systematic review investigates the possible role of hyperinflammation in inducing cardiac injury as one of the severe complications of COVID-19. A systematic literature search was performed using PubMed, Embase and Scopus databases to identify relevant clinical studies that investigated cardiovascular injury manifestations and reported inflammatory and cardiac biomarkers in COVID-19 patients. Only 29 studies met our inclusion criteria and the majority of these studies demonstrated significantly elevated inflammatory and cardiac blood markers. It was evident that underlying cardiovascular diseases may increase the risk of developing cardiac injury. However, many COVID-19 patients included in this review, developed different types of cardiac injury without having any underlying cardiovascular diseases. Furthermore, many of these patients were either children or adolescents. Therefore, age and comorbidities may not always be the two main risk factors that dictate the severity and outcome of COVID-19. Further investigations are required to understand the underlying mechanisms of pathogenicity as an urgent requirement to develop the appropriate treatment and prevention strategies. These strategies may specifically target hyperinflammation as a suspected driving factor for some of the severe complications of COVID-19.</p><h2>Other Information</h2><p dir="ltr">Published in: Cardiovascular Revascularization Medicine<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.carrev.2021.04.007" target="_blank">https://dx.doi.org/10.1016/j.carrev.2021.04.007</a></p>2022-02-01T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.carrev.2021.04.007https://figshare.com/articles/journal_contribution/Systemic_Inflammation_May_Induce_Cardiac_Injury_in_COVID-19_Patients_Including_Children_and_Adolescents_Without_Underlying_Cardiovascular_Diseases_A_Systematic_Review/24459133CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/244591332022-02-01T00:00:00Z
spellingShingle Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review
Arwa Saed Aldien (17302849)
Biomedical and clinical sciences
Cardiovascular medicine and haematology
Coronavirus
COVID-19
Inflammation
Cardiac injury
Myocarditis
status_str publishedVersion
title Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review
title_full Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review
title_fullStr Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review
title_full_unstemmed Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review
title_short Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review
title_sort Systemic Inflammation May Induce Cardiac Injury in COVID-19 Patients Including Children and Adolescents Without Underlying Cardiovascular Diseases: A Systematic Review
topic Biomedical and clinical sciences
Cardiovascular medicine and haematology
Coronavirus
COVID-19
Inflammation
Cardiac injury
Myocarditis